36P A point mutation replacing cysteine with arginine at position 382 (C382R) in the transmembrane domain of FGFR2 leads to response to FGF2-inhibitor pemigatinib in chemo-refractory intrahepatic cholangiocarcinoma
Titel:
36P A point mutation replacing cysteine with arginine at position 382 (C382R) in the transmembrane domain of FGFR2 leads to response to FGF2-inhibitor pemigatinib in chemo-refractory intrahepatic cholangiocarcinoma
Auteur:
Hempel, L.C. Lapa, C. Gaumann, A. Veloso de Oliveira, J. Scheiber, J. Philipp, P. Oyarzun, C. Wesarg, S. Robert, S. Hempel, D.